PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 135 filers reported holding PROVENTION BIO INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $733,749 | +132.6% | 30,446 | +2.0% | 0.01% | +150.0% |
| Q4 2022 | $315,409 | +150.3% | 29,840 | +6.5% | 0.00% | +100.0% |
| Q3 2022 | $126,000 | +20.0% | 28,011 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $105,000 | -48.0% | 26,196 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $202,000 | +21.7% | 27,536 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $166,000 | -14.4% | 29,473 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $194,000 | -26.0% | 30,355 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $262,000 | -19.4% | 31,077 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $325,000 | -30.7% | 30,926 | +11.8% | 0.00% | -50.0% |
| Q4 2020 | $469,000 | +28.5% | 27,670 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $365,000 | -0.3% | 28,463 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $366,000 | – | 25,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 6,000,000 | $43,920,000 | 2.10% |
| VR Adviser, LLC | 1,118,653 | $8,189,000 | 1.33% |
| DG Capital Management, LLC | 522,568 | $3,825,000 | 0.77% |
| Atom Investors LP | 42,680 | $312,000 | 0.15% |
| ADVISORY RESEARCH INC | 235,000 | $1,720,000 | 0.14% |
| Perceptive Advisors | 791,549 | $5,794,000 | 0.12% |
| Verition Fund Management LLC | 1,086,593 | $7,954,000 | 0.10% |
| Virtus ETF Advisers LLC | 26,467 | $194,000 | 0.09% |
| 1900 WEALTH MANAGEMENT LLC | 95,555 | $699,000 | 0.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 220,065 | $1,611,000 | 0.06% |